On Friday, Sangamo Therapeutics Inc (NASDAQ: SGMO) was 3.28% up from the session before settling in for the closing price of $0.84. A 52-week range for SGMO has been $0.30 – $3.18.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 0.15% over the last five years. When this article was written, the company’s average yearly earnings per share was at 48.40%. With a float of $214.59 million, this company’s outstanding shares have now reached $224.71 million.
The firm has a total of 183 workers. Let’s measure their productivity. In terms of profitability, gross margin is 91.18%, operating margin of -169.24%, and the pretax margin is -169.74%.
Sangamo Therapeutics Inc (SGMO) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Sangamo Therapeutics Inc stocks. The insider ownership of Sangamo Therapeutics Inc is 4.50%, while institutional ownership is 27.61%.
Sangamo Therapeutics Inc (SGMO) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 48.40% per share during the next fiscal year.
Sangamo Therapeutics Inc (NASDAQ: SGMO) Trading Performance Indicators
You can see what Sangamo Therapeutics Inc (SGMO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.13. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.37.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.52, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach -0.34 in one year’s time.
Technical Analysis of Sangamo Therapeutics Inc (SGMO)
Analysing the last 5-days average volume posted by the [Sangamo Therapeutics Inc, SGMO], we can find that recorded value of 8.46 million was better than the volume posted last year of 5.11 million. As of the previous 9 days, the stock’s Stochastic %D was 20.51%. Additionally, its Average True Range was 0.11.
During the past 100 days, Sangamo Therapeutics Inc’s (SGMO) raw stochastic average was set at 2.93%, which indicates a significant decrease from 26.49% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 113.19% in the past 14 days, which was lower than the 181.01% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.0695, while its 200-day Moving Average is $1.1575. Now, the first resistance to watch is $0.8938. This is followed by the second major resistance level at $0.9211. The third major resistance level sits at $0.9663. If the price goes on to break the first support level at $0.8213, it is likely to go to the next support level at $0.7761. Now, if the price goes above the second support level, the third support stands at $0.7488.
Sangamo Therapeutics Inc (NASDAQ: SGMO) Key Stats
There are 224,710K outstanding shares of the company, which has a market capitalization of 194.73 million. As of now, sales total 176,230 K while income totals -257,830 K. Its latest quarter income was 49,410 K while its last quarter net income were 10,670 K.
